The Asia Pacific Metagenomics Market should witness market growth of 14.7% CAGR during the forecast period (2022-2028).
Misassembles are produced by the existence of repeating DNA sequences that make assembly particularly challenging due to the disparity in the relative number of species within the sample.Misassembles may also entail the combining of sequences from multiple species to produce chimeric contigs. There are numerous assembly programs, the majority of which can leverage information from paired-end tags to improve assembly precision.
Some tools, such as Phrap or Celera Assembler, were intended to be used to assemble single genomes, but they give satisfactory results when used to assemble metagenomic data sets. Using de Bruijn graphs, Velvet assembler and other programs have been tuned for the shorter reads generated by second-generation sequencing.
The restricted number of microbial phyla for which sequenced genomes are available restricts the utility of reference genomes for improving the assembly of the most abundant microbial species. After an assembly has been completed, another problem is "metagenomic deconvolution," or determining which sequences in the sample come from which species. Sequences must be binned to relate community makeup and function in metagenomes.
Utilizing digital healthcare technologies, China responded promptly to the coronavirus outbreak in 2019. Existing research has overlooked the formation of the COVID-19 digital health ecosystem, despite the technical analysis and discussion of genuine digital health breakthroughs. COVID-19 will capture and distribute the key reasons that contributed to China's quick deployment of digital health initiatives, as well as the lessons learned. Medical equipment is the most active and strategically significant part of the healthcare sales industry for international firms.
The China market dominated the Asia Pacific Metagenomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $198.7 Million by 2028.The Japan market is estimated to grow a CAGR of 14% during (2022-2028). Additionally, The India market would experience a CAGR of 15.4% during (2022-2028).
Based on Workflow, the market is segmented into Sequencing, Pre-sequencing and Data Analysis. Based on Product, the market is segmented into Kits & Reagents, Sequencing & Data Analytics Services and Software. Based on Technology, the market is segmented into Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing and Others. Based on Application, the market is segmented into Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Nutrition and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and F. Hoffmann-La Roche Ltd.
Misassembles are produced by the existence of repeating DNA sequences that make assembly particularly challenging due to the disparity in the relative number of species within the sample.Misassembles may also entail the combining of sequences from multiple species to produce chimeric contigs. There are numerous assembly programs, the majority of which can leverage information from paired-end tags to improve assembly precision.
Some tools, such as Phrap or Celera Assembler, were intended to be used to assemble single genomes, but they give satisfactory results when used to assemble metagenomic data sets. Using de Bruijn graphs, Velvet assembler and other programs have been tuned for the shorter reads generated by second-generation sequencing.
The restricted number of microbial phyla for which sequenced genomes are available restricts the utility of reference genomes for improving the assembly of the most abundant microbial species. After an assembly has been completed, another problem is "metagenomic deconvolution," or determining which sequences in the sample come from which species. Sequences must be binned to relate community makeup and function in metagenomes.
Utilizing digital healthcare technologies, China responded promptly to the coronavirus outbreak in 2019. Existing research has overlooked the formation of the COVID-19 digital health ecosystem, despite the technical analysis and discussion of genuine digital health breakthroughs. COVID-19 will capture and distribute the key reasons that contributed to China's quick deployment of digital health initiatives, as well as the lessons learned. Medical equipment is the most active and strategically significant part of the healthcare sales industry for international firms.
The China market dominated the Asia Pacific Metagenomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $198.7 Million by 2028.The Japan market is estimated to grow a CAGR of 14% during (2022-2028). Additionally, The India market would experience a CAGR of 15.4% during (2022-2028).
Based on Workflow, the market is segmented into Sequencing, Pre-sequencing and Data Analysis. Based on Product, the market is segmented into Kits & Reagents, Sequencing & Data Analytics Services and Software. Based on Technology, the market is segmented into Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing and Others. Based on Application, the market is segmented into Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Nutrition and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and F. Hoffmann-La Roche Ltd.
Scope of the Study
By Workflow
- Sequencing
- Pre-sequencing
- Data Analysis
By Product
- Kits & Reagents
- Sequencing & Data Analytics Services
- Software
By Technology
- Shotgun Sequencing
- 16S Sequencing
- Whole Genome Sequencing
- Others
By Application
- Environmental
- Clinical Diagnostics
- Drug Discovery
- Biotechnology
- Food & Nutrition
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Novogene Co., Ltd.
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc. (Takara Holdings Inc.)
- Oxford Expression Technologies Ltd.
- F. Hoffmann-La Roche Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Metagenomics Market by Workflow
Chapter 5. Asia Pacific Metagenomics Market by Product
Chapter 6. Asia Pacific Metagenomics Market by Technology
Chapter 7. Asia Pacific Metagenomics Market by Application
Chapter 8. Asia Pacific Metagenomics Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Novogene Co., Ltd.
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc. (Takara Holdings Inc.)
- Oxford Expression Technologies Ltd.
- F. Hoffmann-La Roche Ltd.
Methodology
LOADING...
